Neogen

Neogen EBITDA Margin

The EBITDA Margin of Neogen (NEOG) as of Oct 20, 2026 is -2.48 %. In the previous year, EBITDA Margin was 1.05 % — a change of -335.69% (lower).

EBITDA Margin

-2.48 %

YoY

-335.69%

Last updated:

EBITDA Margin of Neogen is 2026 -2.48 % . EBITDA Margin of Neogen was 2025 1.05 % . It decreases by -335.69% lower compared to the previous year.

The Neogen EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2019
16.44 USD
Jan 1, 2020
16.15 USD
Jan 1, 2021
15.83 USD
Jan 1, 2022
11.12 USD
Jan 1, 2023
4.56 USD
Jan 1, 2024
8.38 USD
Jan 1, 2025
1.05 USD
Jan 1, 2026
-2.48 USD
The Neogen EBITDA Margin history
YEAREBITDA MarginYoY
-2.48 %-335.69%
1.05 %-87.43%
8.38 %+83.66%
4.56 %-58.98%
11.12 %-29.77%
15.83 %-1.95%
16.15 %-1.78%
16.44 %-5.79%
17.45 %-2.84%
17.96 %+2.34%
17.55 %-6.47%
18.76 %+6.99%
17.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neogen Stock analysis

What does Neogen do? Neogen Corp is a leading provider of food safety and animal health solutions based in Lansing, Michigan, USA. The company was founded in 1982 by James Herbert and initially focused on the development and manufacturing of rapid tests for the dairy industry. Since then, Neogen has become an internationally operating company with over 25 subsidiaries and 1,800 employees. Neogen's business model is based on providing solutions for safe and healthy food supply and animal husbandry. The company operates in two main divisions: Food Safety and Animal Safety. Within these divisions, Neogen offers a wide range of test kits, diagnostic tools, information management software, and other products that help minimize the risk of food poisoning and improve the health of livestock. In the Food Safety division, Neogen offers a variety of test kits that allow food producers and retailers to quickly and easily detect various types of contaminants in food. These include tests for salmonella, E. coli, listeria, and mycotoxins. The company also provides tools for monitoring water quality and verifying cleaning and disinfection processes in food processing plants. In the Animal Safety division, Neogen also offers an extensive range of diagnostic tools to improve the health of livestock. The tests include infectious diseases such as brucellosis, BSE (mad cow disease), mastitis, and leukemia. Additionally, Neogen provides tools for animal identification and animal health data management. Neogen has also specialized in the development of technologies to improve animal health and nutrition, such as probiotics and supplements for livestock. Another focus of Neogen is the development of information management software that enables food producers and retailers to streamline the process of food safety and quality. The software allows companies to track tests, analyze data, and implement best practices to minimize the risk of food poisoning. In recent years, Neogen has also increasingly focused on the global market, especially the Asian market. The company has subsidiaries in various parts of the world, including Europe, Latin America, and Asia. Neogen works closely with local regulatory authorities to offer its products in accordance with local requirements. In conclusion, Neogen Corp is a leading provider of food safety and animal health solutions, focusing on the development and manufacturing of test kits, diagnostic tools, and information management software. The company has experienced impressive growth in recent decades and is now operating internationally. With its commitment to safe and healthy food supply and animal husbandry, Neogen sets industry standards. Neogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neogen stock

EBITDA Margin of Neogen is -2.48 % in 2026.

EBITDA Margin of Neogen changed from 1.05 % to -2.48 %, representing a -335.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Neogen since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Neogen with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Neogen

All Key Metrics — Neogen